Nuvation Stock Analysis

The current indifference towards the small price fluctuations of Nuvation Bio may encourage investors to take a closer look at the firm as it is trading at a share price of 0.0 on very low momentum in trading volume. The company executives did not add any value to Nuvation Bio investors in May. However, most investors can still diversify their portfolios with Nuvation Bio to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Additionally, see Stocks Correlation.

Search Stock Analysis 

 
Refresh
The Nuvation Bio stock analysis report makes it easy to digest most publicly released information about Nuvation Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Nuvation stock analysis module also helps to analyze the Nuvation Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Nuvation Stock Analysis Notes

The company had not issued any dividends in recent years. Nuvation Bio Inc., a biopharmaceutical company, focuses on the development of therapies for oncology. The company was founded in 2018 and is based in New York, New York with an additional office in San Francisco, California. Nuvation Bio operates under Shell Companies classification in the United States and is traded on New York Stock Exchange. To find out more about Nuvation Bio contact the company at 650-245-3818 or learn more at http://www.nuvationbio.com.

Nuvation Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nuvation Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nuvation Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nuvation Bio is not yet fully synchronised with the market data
Nuvation Bio has some characteristics of a very speculative penny stock
Nuvation Bio has high likelihood to experience some financial distress in the next 2 years

Nuvation Bio SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Nuvation Bio prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Nuvation Bio investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Nuvation Bio specific information freely available to individual and institutional investors to make a timely investment decision.
19th of February 2021
Unclassified Corporate Event
View
16th of February 2021
Unclassified Corporate Event
View
12th of February 2021
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
View
11th of February 2021
Unclassified Corporate Event
View
9th of February 2021
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
8th of February 2021
Unclassified Corporate Event
View
4th of December 2020
Unclassified Corporate Event
View
21st of October 2020
Financial Statements and Exhibits. Regulation FD Disclosure. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
View

Nuvation Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 166.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nuvation Bio's market, we take the total number of its shares issued and multiply it by Nuvation Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Nuvation Bio management efficiency ratios could be used to measure how well nuvation bio manages its routine affairs as well as how well it operates its assets and liabilities.

Nuvation Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvation Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvation Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvation Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nuvation Bio Technical and Predictive Indicators

About Nuvation Bio Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvation Bio stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Nuvation Bio. By using and applying Nuvation Stock analysis, traders can create a robust methodology for identifying Nuvation entry and exit points for their positions.
Nuvation Bio Inc., a biopharmaceutical company, focuses on the development of therapies for oncology. The company was founded in 2018 and is based in New York, New York with an additional office in San Francisco, California. Nuvation Bio operates under Shell Companies classification in the United States and is traded on New York Stock Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nuvation Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the Nuvation Bio information on this page should be used as a complementary analysis to other Nuvation Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Tools for Nuvation Bio Stock

When running Nuvation Bio price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go